- IBD
-
Use of thiopurines in inflammatory bowel disease: an update
-
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood
-
Intest Res 2022;20(1):11-30. Published online April 15, 2021
-
DOI: https://doi.org/10.5217/ir.2020.00155
-
-
Abstract
PDF PubReader ePub
- Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD has come under the spotlight. 5-Aminosalicylates, corticosteroids, immunosuppressive agents and biologics are the backbone of treatment of IBD. With the advent of biologics and small molecules, the need for surgery and hospitalization has decreased. However, economic viability and acceptability is an important determinant of local prescription patterns. Nearly one-third of the patients in West receive biologics as the first/initial therapy. The scenario is different in developing countries where biologics are used only in a small proportion of patients with IBD. Increased risk of reactivation of tuberculosis and high cost of the therapy are limitations to their use. Thiopurines hence become critical for optimal management of patients with IBD in these regions. However, approximately one-third of patients are intolerant or develop adverse effects with their use. This has led to suboptimal use of thiopurines in clinical practice. This review article discusses the clinical aspects of thiopurine use in patients with IBD with the aim of optimizing their use to full therapeutic potential.
-
Citations
Citations to this article as recorded by 
- Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited
Ahmed B. Bayoumy, Luc J. J. Derijks, Nanne K. H. de Boer Therapeutic Drug Monitoring.2026; 48(3): 400. CrossRef - Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
Arshdeep Singh, Ajit Sood Indian Journal of Gastroenterology.2026; 45(3): 360. CrossRef - Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS
Carlotta Bidoli, Wenjian Yang, Seth E. Karol, Marianna Lucafò, Gabriele Stocco, Jun J. Yang Clinical Pharmacology & Therapeutics.2026; 119(1): 84. CrossRef - Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles
Andreia S. Barros, Rute Nunes, Bruno Sarmento Journal of Controlled Release.2026; 389: 114466. CrossRef - The right drug at the right time: key to IBD success
Davide Giuseppe Ribaldone, Giulia Valdiserra, Clelia Di Salvo, Ilaria Puxeddu, Lorenzo Bertani, Luca Antonioli Trends in Molecular Medicine.2026; 32(7): 658. CrossRef - Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients
Asghar Ali, Khalid I. AlHussaini Frontiers in Microbiology.2026;[Epub] CrossRef - Risk of Infection Before and After Thiopurine Therapy in Inflammatory Bowel Disease
Johanna Holmgren, Alice Akhlaghi, Isabel Drake, Olof Grip Journal of Clinical Gastroenterology.2026;[Epub] CrossRef - Beyond the binary: understanding inflammatory bowel disease in the context of HIV-induced immunodeficiency
Harsh Srivastava, Tanisha Sehgal, Vishal Sharma, Himanshu Narang, Jeffrey Berinstein, Ajit Sood, Shrinivas Bishu, Manjeet Kumar Goyal Expert Review of Clinical Immunology.2026; 22(3): 307. CrossRef - Optimizing mercaptopurine therapy in indian pediatric ALL: The role of TPMT and NUDT15 genetic polymorphisms
Jayalakshmi Venugopal, Shalini Sivadasan, Rajasekaran Aiyalu Cancer Treatment and Research Communications.2026; 47: 101173. CrossRef - The decline of 6‐thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease
Dianne G. Bouwknegt, Paola Mian, Femke Groen, Denise van den Berg‐Zuiddam, Andrea E. van der Meulen, Femke Crouwel, Nanne K. de Boer, Debbie S. Deben, Dennis R. Wong, Luc J. J. Derijks, Gerard Dijkstra, Arno R. Bourgonje, C. Janneke van der Woude, Marijn British Journal of Clinical Pharmacology.2026; 92(7): 2364. CrossRef - Efficacy and Safety of Etrasimod in Moderate-To-Severe Ulcerative Colitis: A GRADE-Based Systematic Review and Meta-Analysis of Randomized Controlled Trials
Anurag Jha, Nirmal Paudel, Khawaja Arham Jawaid, Muhammad Haad Munir Chaudhry, Zain Ali, Farhan Javaid, Shazia Sharif, Ayesha Asghar, Muhammad Saad, Muhammad Nabeel Saddique Annals of Pharmacotherapy.2026; 60(12): 1156. CrossRef - Adverse Events Related to Azathioprine Use in Patients With Inflammatory Bowel Disease: A Real‐World Cohort Study
Mukesh Kumar Ranjan, Pradeep Neupane, Bigyan Maharjan, Manoj Lamsal, Bikash Poudel, Tatsuya Toyokawa Gastroenterology Research and Practice.2026;[Epub] CrossRef - Colorectal cancer in ulcerative colitis: unraveling mechanisms and advancing surveillance and chemoprevention
Haiyan Lu, Xiangdang Hu, Yan Chen, Jie He Frontiers in Oncology.2026;[Epub] CrossRef - Development and Validation of an Ultra-high Performance Liquid Chromatography Method for Simultaneous Quantification of Phosphorylated Thiopurine Metabolites in Patients with Inflammatory Bowel Disease
Khushboo G. Upadhyay, Mihika B. Dave, Devendra C. Desai, Prasad R. Naik, Sarita D. Pol, Rohan V. Lokhande, Tester F. Ashavaid, Alpa J. Dherai Indian Journal of Clinical Biochemistry.2026;[Epub] CrossRef - Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease
Eun Kyung Boo, Jongwook Yu, Sohyung Oh, Jae Hee Cheon, Ju Han Kim Yonsei Medical Journal.2026; 67(8): 603. CrossRef - Disability among Palestinian patients with inflammatory bowel disease: evaluation using the IBD Disk and identification of associated factors
Ahmed Quraish, Ro’ya Khanfar, Karmil Kharouf, Sami Salous, Dala Quraish, Qusay Abdoh Crohn’s & Colitis 360.2026;[Epub] CrossRef - The JAK attack: transforming the management of ulcerative colitis in India
Arshdeep Singh, Arshia Bhardwaj, Vandana Midha, Ajit Sood Intestinal Research.2026; 24(3): 392. CrossRef - Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework
Khaled H. Husain, Hira Khan, Bianca Thakkar, Musa Bungish, Haleh Vaziri Digestive Diseases and Sciences.2026; 71(11): 6100. CrossRef - Management of Pediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Dror S Shouval, Iva Hojsak, Erasmo Miele, Christiane Sokollik, Dan Turner, Kaija-Leena Kolho, Rotem Sigall-Boneh, Patrick F van Rheenen, Eytan Wine, Richard K Russell, Seamus Hussey, Neil Chanchlani, Amit Assa, Javier Martin de Carpi, Luca Scarallo, Anne Journal of Crohn’s and Colitis.2026;[Epub] CrossRef - Inflammatory Bowel Disease: From Multifactorial and Metabolic Pathogenesis to Systemic Disease and Precision Medicine
Vinícius Pedro Silva de Oliveira, Elizangela dos Anjos Silva, Silvio Pires Gomes Metabolites.2026; 16(10): 710. CrossRef - Model-Informed Precision Dosing of Thiopurines in Inflammatory Bowel Disease through Pharmacometric Integration of TPMT and NUDT15 Genotypes
P. Thilagesh, U. Aiswarya Nair, S. Anand Kumar, Akshaya Krishnan, S. Gokilavani, M. Kalpana Devi, M. Shankar Ganesh Current Pharmacogenomics and Personalized Medicine.2026;[Epub] CrossRef - Thiopurines and vitamin K antagonist resistance: warfarin inhibits thiopurine S-methyltransferase
A. B. Bayoumy, D. A. Russell, A. A. M. Zandbergen, R. A. Totah Journal of Thrombosis and Thrombolysis.2026;[Epub] CrossRef - KASID Guidelines for the Medical Treatment of Ulcerative Colitis: 2026
Dong Hyun Kim, Seung Min Hong, Seung Yong Shin, June Hwa Bae, Eun Mi Song, Ji Eun Kim, Young Joo Yang, Jiyoung Yoon, Sang-Bum Kang, Eun Soo Kim, Seong-Eun Kim, Seong-Jung Kim, Jun Lee, Soo-Young Na, Soo Jung Park, Sang Hyoung Park, Myung Ha Kim, Miyoung C The Korean Journal of Gastroenterology.2026; 86(4): 352. CrossRef - Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy
Rujirada Phoojaroenchanachai, Thanaboon Chaemsupaphan, Onuma Sattayalertyanyong, Nichcha Subdee, Phutthaphorn Phaophu, Marianee Salaemae, Julajak Limsrivilai Crohn’s & Colitis 360.2026;[Epub] CrossRef - Intestinal Diseases in Men and Women: Etiology, Diagnosis, and Therapeutic Approaches
Erik Shorabaev, Amankeldi Sadanov, Saltanat Orazymbet, Irina Ratnikova, Baiken Baimakhanova, Altynai Mambaeva, Mira Azhakhmetova, Yelena Shorina, Gulzakira Xetayeva, Akmaral Maimakova, Aziza Kudaibergen, Aknur Turgumbayeva Diseases.2026; 14(11): 392. CrossRef - Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease
Arshdeep Singh, Vandana Midha, Ajit Sood Indian Journal of Gastroenterology.2025; 44(3): 390. CrossRef - Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease
Tracy Coelho, Guo Cheng, Sophie Lewis, James J Ashton, Farah Barakat, Kouros C T Driscoll, Adebola E Sholeye-Bolaji, Akshay Batra, Nadeem A Afzal, Robert M Beattie, Sarah Ennis Inflammatory Bowel Diseases.2025; 31(2): 362. CrossRef - Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. A Saudi Journal of Gastroenterology.2025; 31(3): 107. CrossRef - Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, John Gubatan, Geert D’Haens Drugs.2025; 85(1): 67. CrossRef - Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
Hansol Kim, Yoon Zi Kim, Seon Young Kim, Yon Ho Choe, Mi Jin Kim Clinical Therapeutics.2025; 47(3): 196. CrossRef - Thiopurine S-methyltransferase – An important intersection of drug-drug interactions in thiopurine treatment
Dunja Urbančič, Marko Jukič, Alenka Šmid, Stanislav Gobec, Janez Jazbec, Irena Mlinarič-Raščan Biomedicine & Pharmacotherapy.2025; 184: 117893. CrossRef - Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
Abhirup Chatterjee, Prateek Bhatia, Saroj K Sinha, Anupam K Singh, Harshal S Mandavdhare, Jimil Shah, Vaneet Jearth, Arpit Sasani, Aravind Sekar, Minu Singh, Usha Dutta, Vishal Sharma Expert Review of Clinical Pharmacology.2025; 18(3): 175. CrossRef - Cutting Edge: A Comprehensive Guide to Colorectal Cancer Surgery in Inflammatory Bowel Diseases
Ionut Iordache, Lucian-Flavius Herlo, Razvan Popescu, Daniel Costea, Luana Alexandrescu, Adrian Suceveanu, Sorin Deacu, Gabriela Baltatescu, Alina Nicoara, Nicoleta Leopa, Andreea Nelson Twakor, Andrei Iordache, Liliana Steriu Journal of Mind and Medical Sciences.2025; 12(1): 6. CrossRef - Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis
Yuan-Ting Qu, Jia-Yuan Ding, Wei Pan, Fang-Rui Liu, Ai-Lian Dong Frontiers in Medicine.2025;[Epub] CrossRef - Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
Mila Lovrić, Kristina Dukić, Silvija Čuković-Čavka, Lana Ganoci, Nada Božina, Vladimir Trkulja Therapeutic Drug Monitoring.2025; 47(5): 676. CrossRef - Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park Intestinal Research.2025; 23(2): 129. CrossRef - The fate of thiopurine metabolites after switching to low‐dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis
Ahmed B. Bayoumy, Hedwig M. A. D'Agnolo, Nanne K. H. de Boer, Chris J. J. Mulder, Luc J. J. Derijks British Journal of Clinical Pharmacology.2025; 91(10): 2865. CrossRef - Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Ga Hee Park, Jimin Lee, Ju Hyun Lee, Chae Young Kim, Bruce E San Inflammatory Bowel Diseases.2025; 31(10): 2714. CrossRef - NDP52 and its emerging role in pathogenesis
Krenare Bruqi, Flavie Strappazzon Cell Death & Disease.2025;[Epub] CrossRef - Gut microbial healing in IBD: visionary approach or evidence-based reality?
Linda Nanni, Marco Murgiano, Chieh-En Hsu, Sheida Khalili, Giovanni Cammarota, Alfredo Papa, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso Expert Review of Gastroenterology & Hepatology.2025; 19(8): 833. CrossRef - Editorial: Evolving Trends in Ulcerative Colitis Management—Insights From the Lothian Cohort
Shintaro Akiyama Alimentary Pharmacology & Therapeutics.2025; 62(7): 747. CrossRef - Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease
Francesca Tavano, Orazio Palmieri, Maria Latiano, Domenica Gioffreda, Tiziana Latiano, Maria Guerra, Giuseppina Martino, Maria Rosa Valvano, Fabrizio Bossa, Francesco Perri, Anna Latiano International Journal of Molecular Sciences.2025; 26(16): 7860. CrossRef - Assessment of Azathioprine-Associated Lymphopenia Incidence Rates in Polish Children with Inflammatory Bowel Disease and Autoimmune Hepatitis: A Retrospective Study
Katarzyna Bąk-Drabik, Anna Kaput, Anna Jarzumbek, Katarzyna Górowska-Kowolik, Agnieszka Szymlak, Agnieszka Krzywicka, Piotr Adamczyk, Jarosław Kwiecień Children.2025; 12(8): 1093. CrossRef - Inflammatory bowel disease in paediatrics: Navigating the old challenges and emerging frontiers
Mohammed Al-Beltagi, Nermin K Saeed, Prabu Kumar Chokkalingam Mani, Adel S Bediwy, Reem Elbeltagi World Journal of Gastroenterology.2025;[Epub] CrossRef - Enhancing Crohn’s disease management during pregnancy: innovations in therapeutic approaches and cutting-edge monitoring practices
Mustafa Goksu, Ozan Karadeniz, Aycan Orler, Pinar Kadirogullari BMC Pregnancy and Childbirth.2025;[Epub] CrossRef - Inflammatory Bowel Disease and Pharmacotherapeutic Treatment for Healthcare Providers: A Pedagogic Tutorial
Charlotte Silvestre, Julien Antih, Baptiste Perrier, Lucas Fabrega, Florence Bichon, Patrick Poucheret Gastrointestinal Disorders.2025; 7(3): 58. CrossRef - Recent developments in biomarker guided therapy for Crohn’s disease
André Bargas, Joana Torres, Bram Verstockt Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1241. CrossRef - Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles
Tugce Eskazan, Oguz Kagan Bakkaloglu, Murat Toruner, Haluk Tarik Kani, Bilger Cavus, Volkan Yilmaz, Nalan Gulsen Unal, Ozlen Atug, Burhan Cagcag, Mehtap Dogruel, Erkan Yilmaz, Filiz Akyuz, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Aykut Ferhat Celik Journal of Clinical Medicine.2025; 14(23): 8539. CrossRef - Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
Arshdeep Singh, Arshia Bhardwaj, Harmeet Kaur, Ashutosh Bawa, Vandana Midha, Ajit Sood World Journal of Hepatology.2025;[Epub] CrossRef - Medical Management of Inflammatory Bowel Disease
Shahrose Rahman, Ranish K. Patel, Elisa Boden, Vassiliki Liana Tsikitis Surgical Clinics of North America.2024; 104(3): 657. CrossRef - Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study
Arshdeep Singh, Vandana Midha, Kirandeep Kaur, Ramit Mahajan, Dharmatma Singh, Ramandeep Kaur, Aditya Kohli, Avantika Chawla, Kriti Sood, Namita Bansal, Ajit Sood Journal of Crohn's and Colitis.2024; 18(2): 300. CrossRef - Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion
Yasunori Fukumoto, Rin Kyono, Yuka Shibukawa, Yu-ki Tanaka, Noriyuki Suzuki, Yasumitsu Ogra Journal of Biological Chemistry.2024; 300(2): 105599. CrossRef - Factors Associated with Reaching Mid-Parental Height in Patients Diagnosed with Inflammatory Bowel Disease in Childhood and Adolescent Period
So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang Gut and Liver.2024; 18(1): 106. CrossRef - Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, Ramit Mahajan, Kirandeep Kaur, Yogesh Kumar Gupta, Dharmatma Singh, Namita Bansal, Ramandeep Kaur, Shivam Kalra, Omesh Goyal, Varun Mehta, Ajit Sood American Journal of Gastroenterology.2024; 119(7): 1365. CrossRef - Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis
Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Ramandeep Kaur, Shreya Garg, Kirti Arora, Namita Bansal, Ajit Sood Digestive Diseases and Sciences.2024; 69(4): 1389. CrossRef - Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
Ahmed B. Bayoumy, Chris J. J. Mulder, Azhar R. Ansari, Murray L. Barclay, Tim Florin, Marianne Kiszka-Kanowitz, Luc Derijks, Vishal Sharma, Nanne K. H. de Boer Indian Journal of Gastroenterology.2024; 43(1): 36. CrossRef - The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study
Helena Gensmyr-Singer, Mårten Werner, Pontus Karling Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef - Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing
Ralley Prentice, Emma Flanagan, Emily Wright, Lani Prideaux, William Connell, Miles Sparrow, Peter De Cruz, Mark Lust, Winita Hardikar, Rimma Goldberg, Sara Vogrin, Kirsten Palmer, Alyson Ross, Megan Burns, Tessa Greeve, Sally Bell Journal of Crohn's and Colitis.2024; 18(7): 1081. CrossRef - Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park Yonsei Medical Journal.2024; 65(5): 265. CrossRef - Application of Drug Repurposing Approach for Therapeutic Intervention
of Inflammatory Bowel Disease
Mohammad Aadil Bhat, Iqra Usman, Suneela Dhaneshwar Current Reviews in Clinical and Experimental Pharmacology.2024; 19(3): 234. CrossRef - Selecting first-line advanced therapy for ulcerative colitis: A clinical application of personalized medicine
Mariam S. Mukhtar, Mahmoud H. Mosli Saudi Journal of Gastroenterology.2024; 30(3): 126. CrossRef - Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C. Carmichael, Byung Soh Min Yonsei Medical Journal.2024; 65(7): 380. CrossRef - Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef - Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang Gut and Liver.2024; 18(4): 667. CrossRef - Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Tracy Coelho, Guo Cheng, Fernando Vazquez Lopez, James J Ashton, Robert M Beattie, Sarah Ennis Inflammatory Bowel Diseases.2024; 30(10): 1928. CrossRef - Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
Aleksandra Strigáč, Miłosz Caban, Ewa Małecka-Wojciesko, Renata Talar-Wojnarowska Journal of Clinical Medicine.2024; 13(16): 4678. CrossRef - Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model
Rabeya Jafrin Mow, Michal Pawel Kuczma, Xiaodi Shi, Sridhar Mani, Didier Merlin, Chunhua Yang Nanomaterials.2024; 14(22): 1800. CrossRef - Personalization of thiopurine therapy: Current recommendations and future perspectives
Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan Acta Pharmaceutica.2024; 74(3): 355. CrossRef - Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis
Brigid Pinnuck, Kate D. Lynch Expert Opinion on Pharmacotherapy.2024; 25(13): 1835. CrossRef - Ulcerative colitis: molecular insights and intervention therapy
Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang Molecular Biomedicine.2024;[Epub] CrossRef - Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
Kyeong-Ryoon Lee, Aneela Gulnaz, Yoon-Jee Chae Pharmaceutics.2024; 16(11): 1431. CrossRef - Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss
Jeremy A. Klein, Joëlle St-Pierre, David Choi, Jacqueline Lopez, David T. Rubin ACG Case Reports Journal.2024; 11(11): e01544. CrossRef - Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai International Immunopharmacology.2023; 116: 109597. CrossRef - Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression
Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian, Vishal Sharma Clinics and Research in Hepatology and Gastroenterology.2023; 47(7): 102155. CrossRef - Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park Gut and Liver.2023; 17(4): 581. CrossRef - Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im Intestinal Research.2023; 21(3): 353. CrossRef - The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon Reproductive Medicine.2023; 4(3): 180. CrossRef - Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
Rohan V Yewale, Balakrishnan S Ramakrishna, Babu Vinish Doraisamy, Pandurangan Basumani, Jayanthi Venkataraman, Kayalvizhi Jayaraman, Ananthavadivelu Murali, Karunakaran Premkumar, Akkim Sathish Kumar JGH Open.2023; 7(9): 599. CrossRef - Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon Therapeutic Advances in Gastroenterology.2023;[Epub] CrossRef -
Oral Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Spore Powder Ameliorates Murine Colitis by Inhibiting Key Kinases Phosphorylation in MAPK Pathway
Yingying Zhao, Liangchen Zhu International Journal of Medicinal Mushrooms.2023; 25(10): 39. CrossRef - Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery
Mehrab Pourmadadi, Arsalan Rahmani Ghohrodi, Zeinab Savari, Ehsan Talebi, Iman Ahamdi, Abbas Rahdar, Sadanand Pandey Next Nanotechnology.2023; 2: 100018. CrossRef - Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
Fiona Yeaman, Amelie Stritzke, Verena Kuret, Nastaran Sharifi, Cynthia H Seow, Amy Metcalfe, Yvette Leung Crohn's & Colitis 360.2023;[Epub] CrossRef - Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, Archana Sharbidre, Bipinraj Kunchiraman Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef - Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung Journal of Personalized Medicine.2022; 12(3): 507. CrossRef - Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
Bipadabhanjan Mallick, Sarthak Malik Cureus.2022;[Epub] CrossRef - Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?
Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, Anna Viola Drugs & Aging.2022; 39(6): 441. CrossRef - Personalized medicine in inflammatory bowel disease: Perspectives on Asia
Su Hyun Park, Sang Hyoung Park Journal of Gastroenterology and Hepatology.2022; 37(8): 1434. CrossRef - Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
Jung-Bin Park, Sang Hyoung Park Intestinal Research.2022; 20(3): 279. CrossRef - Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
Jihye Park, Jae Hee Cheon The Korean Journal of Internal Medicine.2022; 37(5): 895. CrossRef - Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park The Korean Journal of Gastroenterology.2022; 80(2): 51. CrossRef - Vaccination strategies for Korean patients with inflammatory bowel disease
Yoo Jin Lee, Eun Soo Kim The Korean Journal of Internal Medicine.2022; 37(5): 920. CrossRef - Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
Jongwook Yu, Soo Jung Park, Hyung Wook Kim, Yun Jeong Lim, Jihye Park, Jae Myung Cha, Byong Duk Ye, Tae Oh Kim, Hyun-Soo Kim, Hyun Seok Lee, Su Young Jung, Youngdoe Kim, Chang Hwan Choi Gut and Liver.2022; 16(5): 764. CrossRef - A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
Debbie S. Deben, Rob H. Creemers, Arjan J. van Adrichem, Roosmarie Drent, Audrey H. H. Merry, Mathie P. G. Leers, Adriaan A. van Bodegraven, Dennis R. Wong Scientific Reports.2022;[Epub] CrossRef - Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
Alexander Keith Turbayne, Miles Patrick Sparrow Digestive Diseases and Sciences.2022; 67(12): 5382. CrossRef - NUDT15Genotyping in Thiopurine Drug Therapy
Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee Laboratory Medicine Online.2022; 12(4): 217. CrossRef - Personalized medicine to implementation science: Thiopurines set for the leap
Vishal Sharma, Saurabh Kedia, Vineet Ahuja JGH Open.2022; 6(10): 651. CrossRef - Immunomodulators: still having a role?
Jeffery M Venner, Charles N Bernstein Gastroenterology Report.2022;[Epub] CrossRef - Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
You Sun Kim Journal of the Korean Medical Association.2021; 64(9): 596. CrossRef - Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
Jin Wook Lee, Eun Soo Kim Gut and Liver.2021; 15(5): 639. CrossRef - Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
Ji Young Chang, Jae Hee Cheon Precision and Future Medicine.2021; 5(4): 151. CrossRef - Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven Expert Opinion on Drug Metabolism & Toxicology.2021; 17(12): 1433. CrossRef
-
33,984
View
-
802
Download
-
99
Web of Science
-
101
Crossref
|